Antares pharma q2 earnings per share $0.01

Antares pharma reports strong second quarter 2020 operating and financial results; reinstates full-year 2020 revenue guidance.q2 earnings per share $0.01.q2 revenue $32.4 million versus refinitiv ibes estimate of $30.4 million.q2 earnings per share estimate $-0.00 -- refinitiv ibes data.sees fy 2020 revenue $135 million to $155 million.
ATRS Ratings Summary
ATRS Quant Ranking